SCHEMBL2722467

SCHEMBL2722467

CC(C)c1cccc(C(NC2CCN(C)CC2)c2nc3ccccc3[nH]2)c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MLKL Q8NB16 2/20 0.43
▸ HRH4 Q9H3N8 3/20 0.41
▸ PDE10A Q9Y233 1/20 0.41
▸ LMNA P02545 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ VCP P55072 3/20 0.37
▸ ALPL P05186 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HTR3A P46098 1/20 0.37
▸ SCN10A Q9Y5Y9 1/20 0.37
▸ TSHR P16473 1/20 0.36
▸ TAAR1 Q96RJ0 1/20 0.36
▸ IDO1 P14902 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ TRPC3 Q13507 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL900372 0.90 ALPL (0.41) MLKLHRH4PDE10ALMNAKMT2A
SCHEMBL2720358 0.89 HRH4 (0.45) MLKLHRH4LMNAKMT2ASMN1; SMN2
SCHEMBL2722838 0.89 HRH4 (0.40) MLKLHRH4LMNAKMT2ASMN1; SMN2
SCHEMBL2722093 0.89 KMT2A (0.41) MLKLHRH4LMNAKMT2AVCP
SCHEMBL2723739 0.89 VCP (0.40) HRH4PDE10AKMT2AVCPALPL
SCHEMBL2720674 0.89 HRH4 (0.40) HRH4LMNAVCPHTR3ATSHR
SCHEMBL899828 0.89 HRH4 (0.42) MLKLHRH4LMNAKMT2ASMN1; SMN2
SCHEMBL2721765 0.87 PDE10A (0.42) MLKLHRH4PDE10ALMNAKMT2A
SCHEMBL2721609 0.87 HRH4 (0.39) HRH4LMNAKMT2ASMN1; SMN2VCP
SCHEMBL2720491 0.87 HRH4 (0.39) MLKLHRH4LMNAKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3378476-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS Sensorion (FR) 2018-09-26 — — EP disclosed
US-9688989-B2 H4 receptor inhibitors for treating tinnitus SENSORION (FR) 2017-06-27 — — US disclosed
EP-2621916-B1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET SOC CIV (FR) 2016-02-10 — — EP disclosed
US-20150176010-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS SENSORION (FR) 2015-06-25 — — US disclosed
EP-2447263-A1 Benzazole derivatives as histamine H4 receptor ligands BIOPROJET (FR) 2012-05-02 — — EP disclosed
Send feedback